These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33372009)

  • 1. Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.
    Fu EL; Evans M; Clase CM; Tomlinson LA; van Diepen M; Dekker FW; Carrero JJ
    J Am Soc Nephrol; 2021 Feb; 32(2):424-435. PubMed ID: 33372009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of RAAS Inhibition in Children with Advanced CKD.
    van den Belt SM; Heerspink HJL; Kirchner M; Gracchi V; Thurn-Valsassina D; Bayazit AK; Niemirska A; Canpolat N; Kaplan Bulut I; Azukaitis K; Duzova A; Bacchetta J; Shroff R; Paripovic D; Özçakar ZB; Fidan K; Erdogan H; Gellermann J; Wühl E; de Zeeuw D; Melk A; Querfeld U; Schaefer F
    Clin J Am Soc Nephrol; 2020 May; 15(5):625-632. PubMed ID: 32253275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
    Bhandari S; Mehta S; Khwaja A; Cleland JGF; Ives N; Brettell E; Chadburn M; Cockwell P;
    N Engl J Med; 2022 Dec; 387(22):2021-2032. PubMed ID: 36326117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study.
    Fu EL; Evans M; Carrero JJ; Putter H; Clase CM; Caskey FJ; Szymczak M; Torino C; Chesnaye NC; Jager KJ; Wanner C; Dekker FW; van Diepen M
    BMJ; 2021 Nov; 375():e066306. PubMed ID: 34844936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
    Weir MR; Lakkis JI; Jaar B; Rocco MV; Choi MJ; Kramer HJ; Ku E
    Am J Kidney Dis; 2018 Dec; 72(6):873-884. PubMed ID: 30201547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality.
    Faucon AL; Fu EL; Stengel B; Mazhar F; Evans M; Carrero JJ
    Kidney Int; 2023 Sep; 104(3):542-551. PubMed ID: 37330214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
    de Rooij ENM; de Fijter JW; Le Cessie S; Hoorn EJ; Jager KJ; Chesnaye NC; Evans M; Windahl K; Caskey FJ; Torino C; Szymczak M; Drechsler C; Wanner C; Dekker FW; Hoogeveen EK;
    Am J Kidney Dis; 2023 Sep; 82(3):257-266.e1. PubMed ID: 37182596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease.
    Bhandari S; Mehta S; Khawaja A; Cleland JGF; Ives N; Cockwell P
    Kidney Int; 2024 Jan; 105(1):200-208. PubMed ID: 37783444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial.
    Saglimbene V; Palmer SC; Ruospo M; Natale P; Maione A; Nicolucci A; Vecchio M; Tognoni G; Craig JC; Pellegrini F; Lucisano G; Hegbrant J; Ariano R; Lamacchia O; Sasso A; Morano S; Filardi T; De Cosmo S; Pugliese G; Procaccini DA; Gesualdo L; Palasciano G; Johnson DW; Tonelli M; Strippoli GFM;
    J Am Soc Nephrol; 2018 Dec; 29(12):2890-2899. PubMed ID: 30420421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between stopping renin-angiotensin system inhibitors immediately before hemodialysis initiation and subsequent cardiovascular events.
    Nakamura Y; Inaguma D; Imaizumi T; Kurasawa S; Hishida M; Okazaki M; Fujishima Y; Nishibori N; Suzuki K; Takeda Y; Maruyama S
    Hypertens Res; 2024 May; 47(5):1372-1379. PubMed ID: 38438724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes.
    Xu Y; Fu EL; Trevisan M; Jernberg T; Sjölander A; Clase CM; Carrero JJ
    Am Heart J; 2022 Jan; 243():177-186. PubMed ID: 34610282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stopping renin-angiotensin system inhibitors in chronic kidney disease: predictors of response.
    Gonçalves AR; Khwaja A; Ahmed AK; El Kossi M; El Nahas M
    Nephron Clin Pract; 2011; 119(4):c348-54. PubMed ID: 22135795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
    Qiao Y; Shin JI; Chen TK; Inker LA; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME
    JAMA Intern Med; 2020 May; 180(5):718-726. PubMed ID: 32150237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.
    Oh YJ; Kim SM; Shin BC; Kim HL; Chung JH; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Lee C; Jung JY
    PLoS One; 2017; 12(1):e0170874. PubMed ID: 28122064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-Angiotensin System Inhibitor is Associated with Lower Risk of Ensuing Chronic Kidney Disease after Functional Recovery from Acute Kidney Injury.
    Chou YH; Huang TM; Pan SY; Chang CH; Lai CF; Wu VC; Wu MS; Wu KD; Chu TS; Lin SL
    Sci Rep; 2017 Apr; 7():46518. PubMed ID: 28406186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.